These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 36625807)

  • 1. Autism Spectrum Disorder: A Review.
    Hirota T; King BH
    JAMA; 2023 Jan; 329(2):157-168. PubMed ID: 36625807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
    Casseus M; Kim WJ; Horton DB
    Autism Res; 2023 Apr; 16(4):855-867. PubMed ID: 36644987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Seven Sites, United States, 2010, 2012, and 2014.
    Christensen DL; Maenner MJ; Bilder D; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Pettygrove SD; Robinson C; Shenouda J; White T; Zahorodny W; Pazol K; Dietz P
    MMWR Surveill Summ; 2019 Apr; 68(2):1-19. PubMed ID: 30973853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials in autism spectrum disorder: evidence, challenges and future directions.
    Anagnostou E
    Curr Opin Neurol; 2018 Apr; 31(2):119-125. PubMed ID: 29389748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.
    Baio J; Wiggins L; Christensen DL; Maenner MJ; Daniels J; Warren Z; Kurzius-Spencer M; Zahorodny W; Robinson Rosenberg C; White T; Durkin MS; Imm P; Nikolaou L; Yeargin-Allsopp M; Lee LC; Harrington R; Lopez M; Fitzgerald RT; Hewitt A; Pettygrove S; Constantino JN; Vehorn A; Shenouda J; Hall-Lande J; Van Naarden Braun K; Dowling NF
    MMWR Surveill Summ; 2018 Apr; 67(6):1-23. PubMed ID: 29701730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
    Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-occurring attention-deficit/hyperactivity disorder and anxiety disorders differentially affect males and females with autism.
    Wodka EL; Parish-Morris J; Annett RD; Carpenter L; Dillon E; Michaelson J; Kim SH; Landa R; ; Kanne S
    Clin Neuropsychol; 2022 Jul; 36(5):1069-1093. PubMed ID: 34315336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
    Lamy M; Erickson CA
    Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.
    Christensen DL; Braun KVN; Baio J; Bilder D; Charles J; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Lee LC; Pettygrove S; Robinson C; Schulz E; Wells C; Wingate MS; Zahorodny W; Yeargin-Allsopp M
    MMWR Surveill Summ; 2018 Nov; 65(13):1-23. PubMed ID: 30439868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.
    Christensen DL; Baio J; Van Naarden Braun K; Bilder D; Charles J; Constantino JN; Daniels J; Durkin MS; Fitzgerald RT; Kurzius-Spencer M; Lee LC; Pettygrove S; Robinson C; Schulz E; Wells C; Wingate MS; Zahorodny W; Yeargin-Allsopp M;
    MMWR Surveill Summ; 2016 Apr; 65(3):1-23. PubMed ID: 27031587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autism Spectrum Disorder: Classification, diagnosis and therapy.
    Sharma SR; Gonda X; Tarazi FI
    Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, Evaluation, and Management of Children With Autism Spectrum Disorder.
    Hyman SL; Levy SE; Myers SM;
    Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31843864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database.
    Feroe AG; Uppal N; Gutiérrez-Sacristán A; Mousavi S; Greenspun P; Surati R; Kohane IS; Avillach P
    JAMA Pediatr; 2021 Sep; 175(9):957-965. PubMed ID: 34097007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Identification of Autism Spectrum Disorder Among Children Aged 4 Years - Early Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2016.
    Shaw KA; Maenner MJ; Baio J; ; Washington A; Christensen DL; Wiggins LD; Pettygrove S; Andrews JG; White T; Rosenberg CR; Constantino JN; Fitzgerald RT; Zahorodny W; Shenouda J; Daniels JL; Salinas A; Durkin MS; Dietz PM
    MMWR Surveill Summ; 2020 Mar; 69(3):1-11. PubMed ID: 32214075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R
    Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological interventions in autism spectrum disorder.
    Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
    Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
    Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
    J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
    Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
    Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.